Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 12.9 | 10.1 | 8.0 | 6.4 | 5.4 | 4.7 | 3.6 | 2.6 |
| Revenue growth | 27.6% | 25.4% | 26.3% | 19.0% | 14.9% | 31.1% | 38.1% | -58.9% |
| Cost of goods sold | 5.8 | 5.4 | 4.4 | 3.5 | 2.7 | 2.6 | 2.2 | 1.5 |
| Gross profit | 7.1 | 4.6 | 3.6 | 2.8 | 2.6 | 2.0 | 1.4 | 1.1 |
| Gross margin | 55.0% | 46.0% | 44.9% | 44.6% | 49.5% | 43.3% | 38.5% | 41.8% |
| Selling, general and administrative | | | | | | | | 6.5 |
| Sales and marketing | 4.6 | 5.0 | 4.3 | 2.8 | 2.6 | 2.7 | 1.9 | |
| Research and development | 0.5 | 0.5 | 0.7 | 1.0 | 1.4 | 1.4 | 2.0 | 2.8 |
| General and administrative | 6.0 | 5.5 | 7.2 | 5.2 | 5.4 | 5.6 | 5.8 | |
| EBITA | -4.0 | -6.4 | -8.6 | -6.1 | -6.7 | -7.6 | 11.1 | -8.5 |
| EBITA margin | -31.0% | -63.8% | -107.4% | -96.5% | -125.7% | -163.8% | 311.1% | -331.3% |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | 0.2 | |
| EBIT | -4.1 | -6.5 | -8.8 | -6.4 | -7.0 | -7.9 | 10.9 | -8.5 |
| EBIT margin | -31.8% | -64.8% | -108.9% | -100.4% | -130.7% | -169.6% | 305.7% | -331.3% |
| Pre-tax income | -4.1 | -6.6 | -8.7 | -3.9 | -9.5 | -7.9 | -5.9 | -11.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 7.2 | 6.2 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.0% | | |
| Net income | -5.8 | -7.7 | -8.7 | -12.2 | -10.3 | -7.6 | -13.1 | -17.6 |
| Net margin | -44.9% | -75.9% | -108.3% | -191.8% | -191.9% | -163.1% | -369.0% | -685.5% |
| |
| Diluted EPS | ($3.27) | ($9.22) | ($11.84) | ($3.10) | ($9.43) | $988,166.45 | ($0.77) | ($1.60) |
| Shares outstanding (diluted) | 1.8 | 0.8 | 0.7 | 3.9 | 1.1 | 0.0 | 7.6 | 7.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|